313 related articles for article (PubMed ID: 18199098)
21. Protective effect of sivelestat, a neutrophil elastase inhibitor, on ipsilateral and contralateral testes after unilateral testicular ischaemia-reperfusion injury in rats.
Tsounapi P; Saito M; Dimitriadis F; Shimizu S; Kinoshita Y; Shomori K; Satoh I; Satoh K
BJU Int; 2011 Jan; 107(2):329-36. PubMed ID: 20575981
[TBL] [Abstract][Full Text] [Related]
22. Early administration of sivelestat, the neutrophil elastase inhibitor, in adults for acute lung injury following gastric aspiration.
Hayashida K; Fujishima S; Sasao K; Orita T; Toyoda Y; Kitano M; Hori S
Shock; 2011 Sep; 36(3):223-7. PubMed ID: 21617577
[TBL] [Abstract][Full Text] [Related]
23. A pilot randomized study of the neutrophil elastase inhibitor, Sivelestat, in patients undergoing cardiac surgery.
Abe T; Usui A; Oshima H; Akita T; Ueda Y
Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):236-40. PubMed ID: 19447800
[TBL] [Abstract][Full Text] [Related]
24. The leukotriene B4 receptor antagonist ONO-4057 inhibits mesangioproliferative changes in anti-Thy-1 nephritis.
Kawasaki Y; Tanji M; Takano K; Fukuda Y; Isome M; Nozawa R; Suzuki H; Hosoya M
Nephrol Dial Transplant; 2005 Dec; 20(12):2697-703. PubMed ID: 16221713
[TBL] [Abstract][Full Text] [Related]
25. CXC receptor 1 and 2 and neutrophil elastase inhibitors alter radiation-induced lung disease in the mouse.
Fox J; Haston CK
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):215-22. PubMed ID: 22929857
[TBL] [Abstract][Full Text] [Related]
26. Influence of neutrophil elastase inhibitor on the postoperative course in patients with esophageal cancer after transthoracic esophagectomy.
Mimatsu K; Oida T; Kawasaki A; Kano H; Kuboi Y; Amano S
Hepatogastroenterology; 2011; 58(110-111):1583-7. PubMed ID: 22086688
[TBL] [Abstract][Full Text] [Related]
27. Sivelestat reduces reperfusion injury of lungs harvested from endotoxin-primed rats by inhibition of neutrophil-mediated inflammation.
Suzuki S; Sugawara T; Tabata T; Oishi H; Niikawa H; Kondo T
J Heart Lung Transplant; 2007 Apr; 26(4):370-5. PubMed ID: 17403479
[TBL] [Abstract][Full Text] [Related]
28. Effect of antiproteolytic drugs: epsilon-aminocaproic acid (EACA) and aprotinin on experimental anti-GBM nephritis.
Hruby Z; Wendycz D; Kopeć W; Czerchawski L; Józefowiak M; Rabczyński J
Nephrol Dial Transplant; 1996 Jan; 11(1):32-9. PubMed ID: 8649650
[TBL] [Abstract][Full Text] [Related]
29. Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction.
Endo S; Sato N; Yaegashi Y; Suzuki Y; Kojika M; Yamada Y; Yoshida Y; Nakadate T; Aoki H; Inoue Y
Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):53-65. PubMed ID: 17974096
[TBL] [Abstract][Full Text] [Related]
30. Sivelestat attenuates postoperative pulmonary dysfunction after total arch replacement under deep hypothermia.
Morimoto N; Morimoto K; Morimoto Y; Takahashi H; Asano M; Matsumori M; Okada K; Okita Y
Eur J Cardiothorac Surg; 2008 Oct; 34(4):798-804. PubMed ID: 18722781
[TBL] [Abstract][Full Text] [Related]
31. [Pretreatment of acid-induced lung injury with specific neutrophil elastase inhibitor ONO-5046 did not exasperate the subsequent bacterial lung infection by Pseudomonas aeruginosa].
Kudoh I; Miyazaki H; Yamada H; Fujimoto J; Ohara M; Tazawa T; Fukushima J; Okumura F
Masui; 2000 Jul; 49(7):724-31. PubMed ID: 10933021
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of Sivelestat in a porcine hepatectomy model prepared using an intermittent Pringle method.
Shimoda M; Iwasaki Y; Okada T; Sawada T; Kubota K
Eur J Pharmacol; 2008 Jun; 587(1-3):248-52. PubMed ID: 18374331
[TBL] [Abstract][Full Text] [Related]
33. Effect of additional preoperative administration of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass.
Kohira S; Oka N; Inoue N; Itatani K; Kitamura T; Horai T; Oshima H; Tojo K; Yoshitake S; Miyaji K
Artif Organs; 2014 Dec; 38(12):1018-23. PubMed ID: 24750107
[TBL] [Abstract][Full Text] [Related]
34. Goto-Kakizaki rat is protected from proteinuria after induction of anti-Thy1 nephritis.
Riley SG; Evans RA; Davies M; Floege J; Phillips AO
Am J Kidney Dis; 2002 May; 39(5):985-1000. PubMed ID: 11979342
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis.
Miyoshi S; Hamada H; Ito R; Katayama H; Irifune K; Suwaki T; Nakanishi N; Kanematsu T; Dote K; Aibiki M; Okura T; Higaki J
Drug Des Devel Ther; 2013; 7():305-16. PubMed ID: 23596346
[TBL] [Abstract][Full Text] [Related]
36. Fatty acid composition of plasma and kidney in rats with anti-Thy1.1 nephritis.
Kumasaka R; Nakamura N; Yamabe H; Osawa H; Shirato K; Shimada M; Murakami R; Fujita T; Okumura K; Hamazaki K; Hamazaki T
In Vivo; 2007; 21(1):77-9. PubMed ID: 17354617
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB.
Hagiwara S; Iwasaka H; Hidaka S; Hasegawa A; Noguchi T
Inflamm Res; 2009 Apr; 58(4):198-203. PubMed ID: 19169649
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of a selective neutrophil elastase inhibitor (sivelestat) on lipopolysaccharide-induced acute dysfunction of the pulmonary microcirculation.
Inoue Y; Seiyama A; Tanaka H; Ukai I; Akimau P; Nishino M; Shimazu T; Sugimoto H
Crit Care Med; 2005 Aug; 33(8):1814-22. PubMed ID: 16096460
[TBL] [Abstract][Full Text] [Related]
39. Potential of sivelestat in protection against severe acute pancreatitis-associated lung injury in rats.
Wang HH; Tang AM; Chen L; Zhou MT
Exp Lung Res; 2012 Nov; 38(9-10):445-52. PubMed ID: 23005337
[TBL] [Abstract][Full Text] [Related]
40. Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
Mitani O; Katoh M; Shigematsu H
Pathol Int; 2004 Apr; 54(4):241-50. PubMed ID: 15028025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
